Acetaminophen and Butalbital and Caffeine

Brand names: Butalbital, Acetaminophen, And Caffeine · Active ingredient: Butalbital, Acetaminophen, Caffeine

In short: Butalbital, acetaminophen, and caffeine tablets USP is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of butalbital, acetaminophen, and caffeine tablets USP in the treatment of multiple recurrent headaches is u

LabelActavis Pharma, Inc.
Label updatedOct 12, 2026

What is Acetaminophen and Butalbital and Caffeine used for?

Butalbital, acetaminophen, and caffeine tablets USP is indicated for the relief of the symptom complex of tension (or muscle contraction) headache.

Evidence supporting the efficacy and safety of butalbital, acetaminophen, and caffeine tablets USP in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.

âš  Boxed warning (FDA's strongest warning)

Acetaminophen has been associated with cases of

acute liver failure, at times resulting in liver

transplant and death. Most of the cases of liver

injury are associated with the use of acetaminophen

at doses that exceed 4000 milligrams per day, and

often involve more than one acetaminophen-containing

product.

Butalbital is habit-forming and potentially abusable. Consequently, the extended use of butalbital, acetaminophen, and caffeine tablets USP is not recommended.

Hepatotoxicity

Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product. The excessive intake of acetaminophen may be intentional to cause self-harm or unintentional as patients attempt to obtain more pain relief or unknowingly take other acetaminophen-containing products.

The risk of acute liver failure is higher in individuals with underlying liver disease and in individuals who ingest alcohol while taking acetaminophen.

Instruct patients to look for acetaminophen or APAP on package labels and not to use more than one product that contains acetaminophen. Instruct patients to seek medical attention immediately upon ingestion of more than 4000 milligrams of acetaminophen per day, even if they feel well. …

Acetaminophen and Butalbital and Caffeine dosage

One or 2 tablets every 4 hours as needed. Total daily dosage should not exceed 6 tablets.

Extended and repeated use of butalbital, acetaminophen, and caffeine tablets USP is not recommended because of the potential for physical dependence.

Warnings & precautions

Do not take this medicine if: Butalbital, acetaminophen, and caffeine tablets USP is contraindicated under the following conditions:

Hypersensitivity or intolerance to any component of this product.

Patients with porphyria.

Butalbital, acetaminophen, and caffeine tablets should be prescribed with caution in certain special-risk patients, such as the elderly or debilitated, and those with severe impairment of renal or hepatic function, or acute abdominal conditions.

Do not take butalbital, acetaminophen, and caffeine tablets USP if you are allergic to any of its ingredients.

If you develop signs of allergy such as a rash or difficulty breathing, stop taking butalbital, acetaminophen, and caffeine tablets USP and contact your healthcare provider immediately.

Do not take more than 4000 milligrams of acetaminophen per day. Call your doctor if you took more than the recommended dose.

Butalbital, acetaminophen, and caffeine tablets USP may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. Such tasks should be avoided while taking this product.

Alcohol and other CNS depressants may produce an additive CNS depression when taken with butalbital, acetaminophen, and caffeine tablets USP, and should be avoided.

Butalbital may be habit-forming. Patients should take the drug only for as long as it is prescribed, in the amounts prescribed, and no more frequently than prescribed.

For information on use in geriatric patients, see

PRECAUTIONS, Geriatric Use

.

In patients with severe hepatic or renal disease, effects of therapy should be monitored with serial liver and/or renal function tests.

The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors. …

Acetaminophen and Butalbital and Caffeine side effects

The most frequently reported adverse reactions are drowsiness, lightheadedness, dizziness, sedation, shortness of breath, nausea, vomiting, abdominal pain, and intoxicated feeling.

All adverse events tabulated below are classified as infrequent.

Central Nervous System:

headache, shaky feeling, tingling, agitation, fainting, fatigue, heavy eyelids, high energy, hot spells, numbness, sluggishness, seizure. Mental confusion, excitement, or depression can also occur due to intolerance, particularly in elderly or debilitated patients, or due to overdosage of butalbital.

Autonomic Nervous System:

dry mouth, hyperhidrosis.

Gastrointestinal:

difficulty swallowing, heartburn, flatulence, constipation.

Cardiovascular:

tachycardia.

Musculoskeletal:

leg pain, muscle fatigue.

Genitourinary:

diuresis.

Miscellaneous:

pruritus, fever, earache, nasal congestion, tinnitus, euphoria, allergic reactions.

Several cases of dermatological reactions, including toxic epidermal necrolysis and erythema multiforme, have been reported.

The following adverse drug events may be borne in mind as potential effects of the components of this product. Potential effects of high dosage are listed in the

OVERDOSAGE

section.

Acetaminophen:

allergic reactions, rash, thrombo-cytopenia, agranulocytosis.

Caffeine:

cardiac stimulation, irritability, tremor, dependence, nephrotoxicity, hyperglycemia.

About this medicine

Butalbital, acetaminophen, and caffeine tablets USP is supplied in tablet form for oral administration.

Each tablet contains the following active ingredients:

butalbital USP……………………… | 50 mg

acetaminophen USP……………… | 325 mg

caffeine USP……………………… | 40 mg

Butalbital (5-allyl-5-isobutylbarbituric acid) is a short- to intermediate-acting barbiturate. It has the following structural formula:

Acetaminophen (4´-hydroxyacetanilide) is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula:

Caffeine (1,3,7-trimethylxanthine) is a central nervous system stimulant. It has the following structural formula:

Inactive Ingredients: crospovidone, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid.

How it works: Butalbital, acetaminophen, and caffeine tablets USP is intended as a treatment for tension headache. It consists of a fixed combination of butalbital, acetaminophen, and caffeine. The role each component plays in the relief of the complex of symptoms known as tension headache is incompletely understood.

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID a6cbc17f-5c60-489c-8029-84b0add556d8. Read the full official label on DailyMed.